期刊文献+

酪氨酸激酶A和血管内皮生长因子受体2在涎腺腺样囊性癌侵袭转移中的作用 被引量:2

Tyrosine kinase A and vascular endothelial growth factor receptor 2 in the invasion and metastasis of salivary adenoid cystic carcinoma
下载PDF
导出
摘要 目的通过检测酪氨酸激酶A(TrkA)与血管内皮生长因子受体2(VEGFR2)在涎腺腺样囊性癌(SACC)的表达情况,探讨TrkA与VEGFR2在SACC侵袭转移中的作用。方法采用免疫组织化学SP法检测47例SACC患者组织病理切片中TrkA与VEGFR2的表达情况,结合临床资料统计分析,评价TrkA、VEGFR2与SACC侵袭转移特性的相关性。结果 TrkA、VEGFR2在SACC组织中的阳性率分别是87.23%(41/47例)和85.11%(40/47例),在有神经侵袭、有复发/转移的SACC患者组织切片中TrkA和VEGFR2的表达率均高于无神经侵袭、未复发/转移者,且差别有统计学意义(P<0.05)。组织内微血管密度(MVD)计数与VEGFR2的表达率成正相关关系;MVD在神经侵袭组为25.14±2.83,在无神经侵袭组为18.81±1.33,两者差异有统计学意义(P<0.05);MVD在复发/转移组为26.58±2.38,未复发/转移组为19.06±1.39(P<0.05)。结论 TrkA、VEGFR2的表达强弱与SACC的嗜神经侵袭,复发转移成正相关关系,提示该2种受体在SACC的侵袭转移过程中具有重要作用,并据此推测TrkA、VEGFR2可以作为评价涎腺腺样囊性癌患者预后的指标。 Objective To determine the effect of tyrosine kinase A(TrkA) and vascular endothelial growth factor receptor 2(VEGFR2) in the invasion and metastasis of salivary adenoid cystic carcinoma(SACC).Methods The expression of TrkA and VEGFR2 were detected by immunohistochemical staining in 47 cases of SACC of salivary glands.Clinical data were reviewed by multivariate prognostic analysis.Results The positive rate of TrkA and VEGFR2 in SACC was 87.23%(41/47) and 85.11%(40/47) respectively.Express of TrkA and VEGFR2 in perineural invasion and recurrence group were higher than non-perineural invasion and non-recurrence group.Significant difference was found in microvessel density(MVD) and VEGFR2 expression within different groups(P〈0.05).MVD in perineural invasion group(25.14±2.83) was significantly higher than that in none perineural invasion group(18.81±1.33)(P〈0.05).MVD in recurrence or metastasis group(26.58±2.38) was significantly higher than tha(t19.06± 1.39) in none recurrence nor metastasis group(P〈0.05).Conclusion Positive correlation between expression of TrkA,VEGFR2 and nerve invasion and vessel metastasis of SACC indicate that TrkA and VEGFR2 play important roles in the invasion and metastasis of SACC.It is possible that TrkA and VEGFR2 could be an aid for evaluating the prognosis of SACC patients.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2010年第4期420-424,429,共6页 West China Journal of Stomatology
基金 国家自然科学基金资助项目(30060082) 教育部春晖计划启动基金资助项目[教外司留(2003)593号] 广西卫生厅医药卫生重点资助项目(重200006和重200927) 广西教育厅基金资助项目(97095) 广西自然科学基金重点资助项目(2010GXNSFD013047)
关键词 酪氨酸激酶A 血管内皮生长因子受体2 涎腺腺样囊性癌 神经侵袭 复发 转移 tyrosine kinase A vascular endothelial growth factor receptor 2 salivary adenoid cystic carcinoma perineural invasion recurrence metastasis
  • 相关文献

参考文献11

  • 1Cheng J,Saku T,Okabe H,et al.Basement membranes in adenoid cystic carcinoma.An immunohistochemical study[J].Cancer,1992,69 (11):2631-2640.
  • 2Wang L,Sun M,Jiang Y,et al.Nerve growth factor and tyrosine kinase A in human salivary adenoid cystic carcinoma:Expression patterns and effects on in vitro invasive behavior[J].J Oral Maxillofac Surg,2006,64(4):636-641.
  • 3王磊,孙沫逸,杨耀武,程晓兵,李建虎.酪氨酸激酶A在涎腺腺样囊性癌中的表达及与嗜神经侵袭的关系[J].中国美容医学,2004,13(2):133-134. 被引量:8
  • 4Pepper MS,Ferrara N,Orci L,et al.Vascular endothelial growth factor (VEGF)induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells[J].Biochem Biophys Res Commun,1991,181(2):902-906.
  • 5Zagzag D.Angiogenic growth factors in neural embryogenesis and neoplasia[J].Am J Pathol,1995,146(2):293-309.
  • 6孙长伏,钟鸣,王兆元,王玉新.涎腺腺样囊性癌神经内分泌性探讨[J].华西口腔医学杂志,1999,17(2):125-127. 被引量:5
  • 7George DJ,Suzuki H,Bora GS,et al.Mutational analysis of the TrkA gene in prostate cancer[J].Prostate,1998,36(3):172-180.
  • 8Descamps S,Lebourhis X,Delehedde M,et al.Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells[J].Biol Chem,1998,273 (27):16659-16662.
  • 9Lalla RV,Boisoneau DS,Spiro JD,et al.Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma[J].Arch Otolaryngol Head Neck Surg,2003,129 (8):882-888.
  • 10陈江,温玉明,李龙江,王昌美.口腔癌血管内皮细胞生长因子(VEGF)表达的初步观察[J].华西口腔医学杂志,2001,19(5):303-305. 被引量:10

二级参考文献9

  • 1周青,王玉新,李瑞武,孙长伏,李辛薇,于丹.口腔颌面部脂肪肉瘤的临床、病理及免疫组化研究[J].中国医科大学学报,1995,24(6):643-644. 被引量:1
  • 2[1]Guidi AJ, Abu-Jawdeh G, Berse B, et al. Vascular permeability factor (vascular endothelial growth factor) expression in cervical neoplasia. J Natl Cancer inst, 1995,87(3):1237~1241
  • 3[2]Devorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor. Microvascular hyperpermeability and angiogenesis. Am J Pathol, 1995,146(3):1029~1032
  • 4[3]Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 1995(a),104(2):744~752
  • 5[4]Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.Hum Pathol, 1995(b),26(1):86~90
  • 6[5]Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int, 1992(a),42(5):1457~1465
  • 7[6]Samoto K, Ikezaki K, Mayumi O, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res, 1995,55(40):1189~1197
  • 8俞光岩,涎腺疾病,1994年,163页
  • 9聂旭光,刘云生,郝宏.头颈部腺样囊性癌的临床病理分析[J].肿瘤防治杂志,2001,8(5):493-494. 被引量:6

共引文献20

同被引文献38

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部